Science as an element of innovation strategy: evidence from the pharmaceutical industry
2013-07
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Science as an element of innovation strategy: evidence from the pharmaceutical industry
Authors
Published Date
2013-07
Publisher
Type
Thesis or Dissertation
Abstract
An extensive literature has informed us that science matters for firm innovation. But the primary question of interest to strategy research in this regard has remained unanswered: what drives the differences among firms in how tightly they couple science with the other elements of their innovation strategy, and what implications do such differences hold for firms' innovativeness. This study takes a first step to answer this question by focusing on the relationship between science and R&D alliances representing key elements of any firm's innovation strategy. Specifically, I conceptualize absorptive capacity as a latent construct that mediates the link between science productivity and the extent of new R&D alliance formations. I then hypothesize that two sets of factors (scientist-based and firm-based) moderate the strength of the baseline relationship by impacting either the resulting absorptive capacity for a given level of science productivity or the substitutability of absorptive capacity as a driver of new R&D alliance formations. I then move on to explore the role of absorptive capacity at the time of forming new R&D alliances on the long-term benefits of those alliance for the firm's innovative output. The results of the analysis of a longitudinal database on 216 publicly-traded pharmaceutical companies in US between 1990 and 2009 provide general support for the proposed theoretical framework of the study.
Keywords
Description
University of Minnesota Ph.D. dissertation. July 2013. Major: Business Administration. Advisor: Aks Zaheer. 1 computer file (PDF); viii, 95 pages.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Vandaie, Ramin. (2013). Science as an element of innovation strategy: evidence from the pharmaceutical industry. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/159368.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.